A recent clinical study lead by the Ablon Institute of Research shows that Nutrafol®, the natural nutraceutical for healthy hair, effectively promote healthy hair growth and improves overall hair quality in women.
The successful results were published in the peer-reviewed Journal of Drugs and Dermatology (JDD), a highly respected resource for dermatologists and researchers worldwide.
“Results from the clinical study showed that 80% of women taking Nutrafol reported significant improvement in their hair growth quality,” says Dr. Glynis Ablon of the Ablon Institute of Research. “We were also delighted to see that subjects taking Nutrafol reported overall improvement in health and wellness in addition to the positive hair parameters. While Nutrafol focuses on hair health, the formula is thoughtfully comprised of pharmaceutical grade botanicals that provide a true inside out approach.”
Since its launch in 2015, Nutrafol has been backed by Unilever Ventures and has invested one-third of its total funds into R&D and clinical testing, becoming the fastest-growing hair growth brand in the direct-to-consumer and professional channels.
Nutrafol aims to disrupt the $7 billion dollar hair loss industry bringing to market next generation healthy hair growth solutions to the 80 millions of American men and women looking to improve their hair health.
“Nutrafol’s approach to product development follows rigorous guidelines that focus on a multi-targeted approach that addresses the multiple factors of poor hair health: including stress, micro-inflammation, hormones and diet,” says Roland Peralta, co-founder and Chief Science and Product Officer at Nutrafol.
“We are thrilled by the results of the clinical study led by the Ablon Institute and are committed to push the boundaries, invest in research and continue to test products far beyond the level of commitment from any nutraceutical in market today”. He added